|
FY2025
9 months to Dec 31, 2025
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net Income Loss | |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Interest income on Trust Account | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Due from related party | |
| Accounts payable | |
| Accrued expenses | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities: | |
| Investment of cash into Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from sale of public units | |
| Proceeds from exercise of over-allotment option | |
| Proceeds from sale of Private Placement Units, net of subscription note receivable | |
| Payment of underwriter fees and commissions | |
| Proceeds from issuance of Class B ordinary shares | |
| Proceeds from promissory note – related party | |
| Payment of promissory note – related party | |
| Payment of offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash – end of period | |
| Supplemental disclosure of non-cash investing and financing activities: | |
| Remeasurement of Class A ordinary shares to redemption value | |
| Sponsor’s transfer of non-managing membership interests to investors |
Loading...
